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ENDAbstract Background: The sentinel node biopsy concept has been gaining popularity in the head
and neck cancer literature and several pilot studies have been published.
Purpose: This study aimed to systematically evaluate the diagnostic accuracy of sentinel lymph
node biopsy in cN0 patients with squamous cell carcinoma of the oral cavity and oropharynx.
Methods: A systematic literature review was performed using MEDLINE from 1980 to 2014 by
combining oral cavity and oropharyngeal SCC keywords with sentinel node biopsy keywords. We
included diagnostic accuracy studies which used neck dissection as a reference test for the sentinel
node biopsy. Study characteristics and measures of accuracy were extracted. Diagnostic accuracy
was calculated from 2 · 2 tables.
Results: A total of 35 studies (1121 patients) were included. The pooled sensitivity, speciﬁcity,
positive likelihood ratio (LR+), negative likelihood ratio, diagnostic odds ratio, positive predictive
value, negative predictive value and accuracy were 93%, 100%, 35.89%, .12%, 282.7%, 100%,
97% and 97.8%, respectively.
Conclusions: High sensitivity, negative predictive value and accuracy of SLNB support its role as
a valid diagnostic technique to correctly stage cN0 patients with OCSCC and OPSCC.
ª 2014 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier
B.V. All rights reserved.1. Introduction
Oral cavity and oropharyngeal squamous cell carcinoma
(OCSCC and OPSCC) are considered an important part of
the global burden of cancer, mainly due to the widespread
use of tobacco and alcohol.1ed.
Table 2 Reported detection rate for the SLNB versus END in evaluation of cN0 neck in patients with OSCC & OPSCC.
Diagnostic tool True positive False positive False negative True negative
SLNB versus END 301 (26.8%) 0 (0%) 24 (2%) 796 (71%)
Table 1 Detailed literature search.
Keywords Number of articles and
their abstracts
Potentially eligible
studies
SLNB+ Oral cavity & Oropharyngeal SCC 185 120
SLNB in clinically negative neck 36 22
SLNB+ Oral cavity & Oropharyngeal SCC+ cN0
neck
83 35
SLNB+ Oral cavity & Oropharyngeal SCC+ cN0
neck + meta analysis
21 5
END+Oral cavity & Oropharyngeal SCC 95 60
END+Oral cavity & Oropharyngeal SCC+ cN0 neck 65 35
END+Oral cavity & Oropharyngeal SCC+ cN0
neck + meta analysis
23 1
SLNB versus END 0 0
SLNB versus END in oral cavity SCC 1 1
SLNB+ END+Oral cavity & Oropharyngeal
SCC+ cN0 neck + meta analysis
16 5
Total 525 284
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vical lymph node metastases, which can decrease the 5-year
survival rates to lower than 50%.2
Staging of the neck by palpation and imaging techniques
(e.g. MRI, CT, ultrasound-guided ﬁne needle aspiration
cytology (USgFNAC)) are not sensitive enough in detecting
micrometastases resulting in a high incidence of occult metas-
tases in the neck.3 These techniques are based primarily on size
criteria, with nodes smaller than 10 mm not generally consid-
ered suspicious. However, nodes as small as 2.0 mm can
contain micrometastatic disease4 and therefore there is still a
20–30% incidence of occult nodal metastasis in necks catego-
rized as N0.5 Exact staging of the N0 neck is therefore crucial
in managing this type of cancer.
In SCC of the oral cavity and oropharynx, the main options
for the treatment of the N0 neck are elective neck dissection,
radiation therapy, or a combination of the two.6
Currently accepted management policies are that patients
with greater than 20% chance of subclinical metastases, based
on the anatomic site and the size of the primary tumor, should
undergo elective neck dissection (END).7 However, such a pol-
icy might still over treat up to 80% of patients, and ENDs
carry with them an associated morbidity.8
Because of the need to accurately stage the neck and to
treat only those most likely to beneﬁt from therapy, much
interest has arisen in sentinel lymph node biopsy (SLNB).
The validity of the concept of SLNB is based on the fact that
tumor cells will spread from the primary site to a single node
or group of nodes (the sentinel nodes), before progressing to
the remainder of the lymph nodes9 i.e. if the sentinel node is
positive for the disease, the patient’s neck is considered to
harbor disease whether any further deposits are found onhistological examination subsequently and therefore there are
no false-positive cases in this scenario.10
The systematic review and meta-analysis were conducted to
assess the diagnostic accuracy of SLNB in evaluation of N0
neck in patients with oral and oropharyngeal squamous cell
carcinoma.2. Methods
2.1. Search for relevant studies
Using MEDLINE database (http://www.pubmed.com), we
conducted a systematic literature search to identify relevant
studies published within the last 34 years (from 1980 up to
25/1/2014). Disease-speciﬁc search terms (cN0 neck, Clinically
negative neck, oral cavity SCC, oropharyngeal SCC) were
combined with diagnostic modality speciﬁc search terms
(SLNB and END) in addition to methodological search term
(met analysis) in all our searches. The electronic searches were
supplemented by scanning the reference lists from retrieved
articles to identify additional studies that may have been
missed during the initial search. It was decided to include only
those studies which are published in English language or trans-
lated to English language; dealing with human subjects, includ-
ing patients who had a concurrent END performed at the time
of SLNB (with histopathological examination for both speci-
mens) in cN0 neck of patients with OCSCC and OPSCC in
order to acquire pathological validation of the SLNB tech-
nique. Also patients in the included studies did not receive
any treatment before being evaluated by these operative tech-
niques. In studies that included patients with different diseases,
Figure 1 Forest plot showing the sensitivities (Random Effect Model) of SLNB versus END in evaluation of cN0 neck in patients with
OCSCC & OPSCC in included studies. (See above-mentioned references for further information.)
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included. Lymph nodes that demonstrated any evidence of car-
cinoma, including micro metastasis and tumor islet cells, were
considered positive. Excluded articles: are those articles which
miss one or more of the above mentioned inclusion criteria,
duplicated studies or those outdated by subsequent ones. Stud-
ies that provided insufﬁcient data to construct a 2 · 2 contin-
gency table were also excluded.
2.2. Study selection and data abstraction
In order to obtain 2 · 2 contingency tables from the included
studies, we extracted or calculated TP, FN and TN. In sentinel
node biopsies, FP results are not possible. For the evaluation,
the number of neck sides, not the number of patients, was
used.
To calculate sensitivity and speciﬁcity, true-positive (TP)
was considered when histopathology of SLNB proved the
presence of the metastatic cervical lymph node. When histopa-
thology of SLNB did not reveal the presence of the metastatic
cervical lymph node and was subsequently conﬁrmed by histo-
pathology of END, it was considered to be true-negative (TN).It was considered false-negative (FN) if the metastatic cervical
lymph node was conﬁrmed in END subsequently to negative
SLNB.
2.3. Quality assessment of primary studies
For each included study, the methodological quality was
assessed by using the Quality Assessment of Studies of Diag-
nostic Accuracy Included in Systematic Reviews (QUADAS)
criteria, which is a 14-item instrument.11 The questions in this
checklist are aimed at establishing the validity of the study
under review – that is, making sure that it has been carried
out carefully, and that the conclusions represent an unbiased
assessment of the accuracy and reliability of the test being eval-
uated. Each question covers an aspect of methodology that is
thought to make a difference to the reliability of a study.
If the quality item was achieved, we give it (+), and () for
the quality item not achieved or data not available. Fulﬁllment
of the methodological quality criteria for the included articles
was considered high, acceptable, or low, when the percentage
of the mean (sum/total) of adherence for all included article
was >70%, 50–70%, or <50%, respectively.12
Figure 2 Forest plot showing the speciﬁcities (Fixed effect model) of SLNB versus END in evaluation of cN0 neck in patients with
OCSCC & OPSCC in included studies. (See above-mentioned references for further information.)
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The primary outcome for analysis is the diagnostic perfor-
mance of SLNB that detected the neck lymph node metastasis
compared with the reference standard of END specimens. For
each individual study we have calculated the following diag-
nostic values: sensitivity, speciﬁcity, positive likelihood ratio
(LR+), negative likelihood ratio (LR) and diagnostic odds
ratio with a conﬁdence interval of 95%. The sum of the
ROC curve was used to estimate the general accuracy of
SLNB. Data were pooled using random or ﬁxed effect model
according to the presence or absence of a signiﬁcant heteroge-
neity. The random effect model incorporated the heterogeneity
of the studies into the analysis of the overall efﬁcacy. The ﬁxed
effect model assumed that data came from a single study that
is, assuming no inter-study heterogeneity.13 Statistical hetero-
geneity among studies was evaluated by the Cochran Q statis-
tic (considered signiﬁcant for p values <0.10) and the I2 test.
Likelihood ratios are metrics that are calculated using a com-
bination of sensitivity and speciﬁcity values. The positive like-
lihood ratio (LR+) is deﬁned as the ratio of sensitivity/
(1  speciﬁcity), whereas the negative likelihood ratio (LR)is deﬁned as the ratio of speciﬁcity/(1  sensitivity). When a
diagnostic test has absolutely no discriminating ability, both
likelihood ratios equal 1. Meta analysis of the collected data
was conducted using the software: Meta-Discª version 1.4.14
3. Result
3.1. Study identiﬁcation and eligibility
Our search identiﬁed 525 potentially relevant studies in MED-
LINE (Table 1). Out of them, there were 284 potentially eligi-
ble studies. We excluded 103 out of the 284 studies because
they miss one or more of the above mentioned inclusion crite-
ria or were duplicated or were outdated by other more recent
ones. Thus, 181 studies remained for possible inclusion and
were retrieved in full text version. After reviewing the full arti-
cle, 146 studies were excluded for the following reasons: some
of them were essay studies while others were containing non
cN0 neck or the primary was non OCSCC and OPSCC. Still
other studies were containing neither SLNB nor END or a
2 · 2 table could not be constructed. This process left 35 origi-
nal articles which fulﬁlled all inclusion criteria and thus were
Figure 3 Forest plot showing the Positive Likelihood Ratios (Fixed effect model) of SLNB versus END in evaluation of cN0 neck in
patients with OCSCC & OPSCC in included studies. (See above-mentioned references for further information.)
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totaled 1121 patients (no of neck sides = 1121).
3.2. Methodological quality assessment of the included studies
Systematic review of the included studies using QUADAS tool
revealed that the total methodological quality score, expressed
as a fraction of the maximum score, ranged from 9/14 (64%)
to 13/14 (93%) with mean (83.3%) (High).
3.3. Analysis of included articles
Our searching of the Medline database revealed 35 studies
which contained 1121 cases in total comparing the roles of
SLN versus END in evaluation of cN0 neck in patients with
OCSCC and OPSCC with the histopathological analysis of
the SLNB and neck dissection specimens as the gold standard.
Most studies mentioned the detection rate of sentinel nodes.
In these studies at least one sentinel node was detected in
almost all patients and a sentinel node biopsy could thus be
performed in all patients. Fifteen studies only included T1-2
N0 oral cavity patients whereas another 4 studies included as
well T3-4 N0. Thirteen studies included T1-2 N0 OCSCC
and OPSCC whereas another 3 studies included as well T3-4
NO OCSCC and OPSCC.The detection rate (true positive) of SLNB versus END
was 301 (26.85%) out of 1121 neck sides, false- negative
results were 24 (2.14%) out of 1121 neck sides and the true
negative results were 796 (71%) out of 1121 neck sides
(Table 2).
The most common method to preoperatively localize SLN
included injecting a radioactive sentinel node tracer followed
by lymphoscintigraphy (in 34 studies). Blue dye was used alone
for localization of SLN in only one study and in addition to
radioactive tracer in 12 studies. 33 studies utilized a gamma
probe intraoperatively in addition to lymphoscintigraphy. In
all studies, the histopathologic examination consisted of serial
sectioning with hematoxylin and eosin (H&E) staining, fol-
lowed by immunohistochemistry staining for negative SLN
in only 21 studies.
The pooled sensitivity of SLNB versus END is 93%. There
is a signiﬁcant heterogeneity between the sensitivities of SLNB
versus END in evaluation of cN0 neck in patients with
OCSCC & OPSCC in included studies as the p value of chi-
square test was 0.06 (<0.1) and I2 index was 28.1% (25–
50%) (Fig. 1).
The pooled speciﬁcity is 100%. There is no signiﬁcant het-
erogeneity between the speciﬁcities of SLNB versus END in
evaluation of cN0 neck in patients with OCSCC & OPSCC
in included studies as the p value of chi square test was
1.0000 (>0.1) and I2 index was 0.0% (0–25%) (Fig. 2).
Figure 4 Forest plot showing the Negative Likelihood Ratios (Fixed effects model) of SLNB versus END in evaluation of cN0 neck in
patients with OCSCC & OPSCC in included studies. (See above-mentioned references for further information.)
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signiﬁcant heterogeneity between the Positive Likelihood
Ratios of SLNB versus END in evaluation of cN0 neck in
patients with OCSCC & OPSCC in included studies as the p
value of chi-square test was 0.999 (>0.1) and I2 index was
0.0% (0–25%) (Fig. 3).
The pooled Negative Likelihood Ratio is 0.12. There is no
signiﬁcant heterogeneity between the Negative Likelihood
Ratio of SLNB versus END in evaluation of cN0 neck in
patients with OCSCC & OPSCC in included studies as the p
value of chi-square test was 0.433 (>0.1) and I2 index was
2.1% (0–25%) (Fig. 4).
The pooled Diagnostic Odds Ratio is 282.73 (denoting high
validity of the test). There is no signiﬁcant heterogeneity of
SLNB versus END in evaluation of cN0 neck in patients with
OCSCC & OPSCC in included studies as the p value of chi-
square test was 0.996 (>0.1) and I2 index was 0.0% (0–25%)
(Fig. 5).
The area under the ROC Curve (AUC) = 0.985 (Fig. 6).
3.4. Diagnostic accuracy
The overall sensitivity (0.93), speciﬁcity (1.00), LR+ (35.89),
LR (0.12), DOR (282.7), AUC (0.985), PPV (1.00), NPV(0.97) and the accuracy (0.978) of SLNB versus END in eval-
uation of N0 neck in patients with OCSCC & OPSCC are
reported in Table 3.
4. Discussion
Although diagnostic tools have developed signiﬁcantly, we
have no effective procedures available to identify hidden met-
astatic disease in the cervical lymph nodes of patients with
OSCC and OPSCC. The incidence is situated at around
30%, a high percentage, and the presence of regional disease
is the cause of the death of one of every two patients.50
The application of SNB has been demonstrated to be very
useful in melanoma and breast cancer51,52 and for this reason
we have studied its application in primary OCSCC and OPS-
CC, through Meta analysis of 35 studies, in an attempt to
determine if SLNB is a useful technique in the diagnosis of
regional metastasis.
It must be noted that all articles in this study have 100%
speciﬁcity (Fig. 2) and positive predictive value because there
are no false-positive cases in this scenario. However, false
negative results can have several causes including uneven
radionuclide injection, obscuring of sentinel lymph nodes by
the radioactive signal of the primary tumor, and lymphatic
Figure 5 Forest plot showing the Diagnostic Odds Ratios (Fixed effects model) of SLNB versus END in evaluation of cN0 neck in
patients with OCSCC & OPSCC in included studies. (See above-mentioned references for further information.)
Figure 6 The Symmetric (A) and plain (B) Receiver-Operating Characteristic curves with its 95% conﬁdence limits for the overall
performance of SLNB as estimated from included studies.
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dictable lymphatic ﬂow and were deﬁned as skip metastases
or jump metastases.8
In our meta-analysis, 1121 patients with OSCC and OPSCC
underwent SLNB followed by immediate END. A positive sen-
tinel lymph node biopsy conﬁrmed occult metastasis in 301neck sides out of 1121 neck sides considered clinically to be
free of disease, equal to 26.85% of our series, which appropri-
ately correlates with the 30% occult metastatic rate, reported
by Don et al.50
Overall, the sensitivity of SLNB in OCSCC and OPSCC
was 93% (Fig. 1), with a NPV of 97% (Table 3). This result
Table 3 Diagnostic performance of SLNB versus END in evaluation of cN0 neck in patients with OCSCC & OPSCC in included
studies.
Diagnostic tool Sensitivity (%) Speciﬁcity (%) LR+ LR DOR AUC PPV (%) NPV (%) Accuracy (%)
SLNB versus END 0.93 1.00 35.89 0.12 282.7 0.985 1.00 0.97 0.978
32 O. Hassan et al.translates to only 3% of necks with negative results actually
being metastatic. Our data demonstrates quite clearly that
OCSCC and OPSCC patients with negative SLNBs can be
assured of a very high degree of certainty that subsequent
ENDs will also be negative.
Our results were concordant with the diagnostic metaanal-
ysis of Govers et al. 2013 (21 studies comprising 847 patients of
cT1/T2N0 oral cavity and oropharyngeal squamous cell carci-
noma)53 and Paleri et al. 2005 (19 studies comprising 301
patients of oral cavity and oropharyngeal squamous cell carci-
noma)54 who reported a pooled sensitivity of 0.94 (0.90–0.97)
and 92.6 (85.2–96.4), respectively.
In the present study, the pooled Positive Likelihood Ratio
of SLNB is 35.89 (Fig. 3). This means that a person with
cN0 neck having metastatic lymphadenopathy is about 36
times more likely to have a positive test than a person with
cN0 neck who has not got metastatic lymphadenopathy in
cases of OCSCC and OPSCC. On the other hand, the pooled
Negative Likelihood Ratio of SLNB is 0.12 (Fig. 4), indicating
that the probability of having a negative test for individuals
with metastatic lymphadenopathy in cN0 neck is 0.12 times
of that of those without metastatic lymphadenopathy in cN0
neck of patients with OCSCC and OPSCC.
In the present study, the pooled Diagnostic Odds Ratio of
SLNB is 282.73 (>1) (Fig. 5). This means that for the SLNB
the odds for positivity among cN0 neck of subjects with met-
astatic lymphadenopathy is nearly 283 times higher than the
odds for positivity among cN0 neck of subjects without meta-
static lymphadenopathy.
In the present study, Area Under Curve (AUC) is equal to
0.985 (Fig. 6) denoting excellent diagnostic value of SLNB ver-
sus END in evaluation of cN0 neck in patients with OCSCC &
OPSCC in included studies.
The present study revealed generally high quality scores of
the included studies; suggesting that most of included studies
presented enough information overall and satisﬁed most of
the requirements established. However most of studies had a
suboptimal design in regard to the blinding method (Item
11) as the interpretation of the histopathological examination
results of the neck dissection specimen was done with the
knowledge of the SLNB histopathological results.
There is no signiﬁcant heterogeneity between the speciﬁcity,
Positive Likelihood Ratio, Negative Likelihood Ratio and
Diagnostic Odds Ratio in the included studies (Figs. 2–5),
while there was a signiﬁcant heterogeneity between the sensi-
tivity in the included studies (Fig. 1) and this was the reason
to adapt a random effect model for data pooling.55
To the best of our knowledge, this is the largest metaanal-
ysis of SLNB in patients with oral cavity and oropharyngeal
SCC.
5. Conclusions
The results of this diagnostic meta-analysis demonstrate that
sentinel node biopsy appears to be a sensitive method in thedetection of neck metastases in cN0 neck of OCSCC and OPS-
CC that could suggest its utility in the management process.6. Recommendations
Multi-center prospective randomized double blind controlled
trials comprising larger patient cohorts comparing the roles
of SLNB versus END in evaluation of cN0 neck in patients
with OCSCC and OPSCC are required. Long-term follow-up
will also be critical to better assess disease free and disease spe-
ciﬁc survival of SLNB patients.
Researchers should pay attention to fulﬁll QUADAS items
specially the blinding.References
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